Generic name: procainamide hydrochloride
Dosage form: Extended-Release Tablets
Medically reviewed on October 17, 2017.
The oral dose and interval of administration should be adjusted for the individual patient, based on clinical assessment of the degree of underlying myocardial disease, the patient’s age, and renal function.
As a general guide, for younger adult patients with normal renal function, an initial total daily oral dose of up to 50 mg/kg of body weight of PRONESTYL-SR Tablets (Procainamide Hydrochloride Extended-Release Tablets) may be used, given in divided doses, every six hours to maintain therapeutic blood levels.
|*Initial dosage schedule guide only, to be adjusted for each patient individually, based on age, cardiorenal function, blood level (if available), and clinical response.|
|To provide approximately 50 mg per kg of body weight per day:*|
|88-100||40-50||500 mg q6h|
|132-154||60-70||750 mg q6h|
|176-198||80-90||1 g q6h|
|>220||>100||1.25 g q6h|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Pronestyl-SR (procainamide)
- Pronestyl-SR Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews
- Drug class: group I antiarrhythmics